Attila V.
- Country
- Hungary
- Department
- Ophtalmology
Research Overview
- A Randomized, Double-masked Study Comparing the Efficacy and Safety of AVT29 Versus High-Dose Aflibercept in Participants with Diabetic Macular Edema
- A Phase 3 Randomized Study Comparing the Efficacy of Vorolanib to Aflibercept in Participants with Diabetic Macular Edema
- Dose-ranging study of FWY003 in geographic atrophy secondary to age-related macular degeneration: randomized, double-masked, placebo-controlled trial in adults
Data & Insights
Has run more than one trial at 175 of 284 partner sites.
Specializations
Ophthalmology and retinal disease
Clinical research in retinal disorders and vision-threatening eye disease is a prominent area of interest, with involvement in studies addressing macular and diabetic retinal complications, as well as degenerative conditions affecting central vision.
- Diabetic macular edema
- Age-related macular degeneration
- Diabetic retinopathy
- Macular neovascularization
- Diabetic eye disease
The research profile also includes interest in ocular imaging, retinal vascular pathology, and treatment approaches for chronic progressive eye conditions seen in the Department of Ophthalmology in Debrecen.
Inflammatory and autoimmune disease
Another major focus is the management of immune-mediated inflammatory disorders, spanning dermatologic, rheumatologic, and systemic autoimmune conditions with persistent inflammatory activity and organ involvement.
- Atopic dermatitis
- Psoriasis
- Psoriatic arthritis
- Rheumatoid arthritis
- Systemic lupus erythematosus
Additional therapeutic interest extends to Sjögren’s disease, systemic sclerosis, vasculitis, and alopecia areata, reflecting engagement with chronic immune dysregulation and targeted anti-inflammatory therapies.
Gastroenterology and hepatology
Research activity includes digestive and liver diseases with emphasis on chronic inflammatory bowel disease, cholestatic liver disorders, and advanced cirrhosis-related complications.
- Crohn’s disease
- Ulcerative colitis
- Primary sclerosing cholangitis
- Hepatic encephalopathy
- Cirrhosis
Therapeutic interests also include non-alcoholic steatohepatitis, metabolic dysfunction-associated steatotic liver disease, and hepatocellular carcinoma, alongside broader work in chronic gastrointestinal inflammation.
Cardiometabolic and thrombotic disease
The investigator is involved in studies of cardiovascular risk, lipid disorders, obesity, and thromboembolic disease, with attention to prevention and treatment across vascular and metabolic disease states.
- Atherosclerotic cardiovascular disease
- Hypercholesterolemia
- Obesity
- Type 2 diabetes
- Venous thromboembolism
Related interests include heart failure, atrial fibrillation, ischemic stroke, and anticoagulation reversal, indicating participation in trials addressing vascular protection and acute cardiovascular care.
Oncology and hematologic malignancy
Clinical trial involvement also spans solid tumors and blood cancers, with a strong presence in malignancies requiring targeted, immunologic, or maintenance-oriented therapeutic strategies.
- Breast cancer
- Non-small cell lung cancer
- Renal cell carcinoma
- Ovarian cancer
- Leukemia and lymphoma
Additional areas include bladder cancer, colorectal cancer, myelodysplastic syndromes, and multiple myeloma, reflecting a broad oncology portfolio across advanced and relapsed disease settings.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.